Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ways And Means Drug Pricing Hearing Emphasizes Repetitive, Years-Old Questions

Executive Summary

There was little on specific legislative proposals and a lot of time discussing broad questions that Congress has been asking for years about drug pricing.

You may also be interested in...



House Drug Pricing Hearing Underscores Democrats' Challenges In Advancing Proposals

Republicans align against Medicare Part D price negotiation bill co-sponsored by Ways and Means Health Subcommittee Chair Lloyd Doggett, D-Tex.

Invitation Accepted: Biopharma Leaders Will Testify At Senate Hearing On Pricing

In addition to fielding tough questions about pricing practices at the session, executives may announce new voluntary efforts to lower drug costs and will offer their own ideas for legislation.

Value-Based Contracting Bill Aims For Bipartisan Political Support

Legislation from Sens. Bill Cassidy and Mark Warner would eliminate barriers to value-based contracting for drugs reimbursed by public payers. 

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS124755

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel